A quarter of adults would consider using an injectable weight loss drug without consulting a health care provider, according to the results of a survey from The Ohio State University Wexner Medical Center.
“I was surprised at how many people were willing to consider medications without a prescription,” Shengyi Mao, MD, an associate professor of clinical medicine at The Ohio State University College of Medicine, told Healio.
A survey asked 1,006 adults what factors — if any — would cause them to not consult a doctor about using a weight loss drug like Ozempic (semaglutide, Novo Nordisk), Wegovy (semaglutide, Novo Nordisk) or Zepbound (tirzepatide, Eli Lilly).
Overall, 25% of respondents said they would consider using a weight loss drug without consulting a doctor. The percentage of respondents who would forgo a consultation was highest among those aged 18 to 29 years.
The study identified several reasons why respondents would opt to use medications without consultation, which included:
the drugs being available at a lower cost online or at a medical spa (18%);
the drugs not being covered by the individual’s insurance (15%);
the individual not being able to receive a prescription from their provider (9%); and
the lack of availability through a pharmacy (6%).
The use of anti-obesity medications has seen substantial changes in the last couple years. glucagon-like peptide-1 receptor agonists increased by 600% among adolescents and young adults from 2020 to 2023, with a particularly significant rise in young women and girls.
However, greater access to weight loss drugs has also led to concern and spotlighted potential risks for adverse events related to the medications.
There are several risks from side effects of weight loss drugs, “such as gastrointestinal symptoms, which are common,” according to Mao.
“More serious effects like pancreatitis, kidney damage [and] hypoglycemia are rare but should be monitored,” she told Healio. “The FDA has issued warnings that dosing errors from compounded medications have resulted in serious complications, with some requiring hospitalization. There is also a concern for thyroid c-cell tumors that were seen in animal studies, so there is a black box warning on these medications for that. Working with a physician can help to minimize risks, monitor side effects and evaluate for efficacy.”
How can physicians address these issues?
“I would ask permission to discuss weight and listen,” Mao explained. “This may allow for an open dialogue to start a partnership in reaching their goals in a safer way.”
She pointed out that more research is needed on the efficacy and safety of weight loss drugs when used over a long period of time.
“We also need to better understand how long patients need to be on these medications or if it’s lifelong,” she said.